PuraPharm Corporation Limited (1498.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 148.66M |
| Enterprise Value | 478.63M |
| P/E Ratio | -4.01 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 0.38 |
| Price/Book Ratio | 0.98 |
| Enterprise/Revenue | 1.48 |
| Enterprise/EBITDA | 12.63 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.09 |
| Operating Margin | -0.05 |
AD
Management Effectiveness
| Return On Assets | -0.04 |
| Return On Equity | -0.22 |
Income Statement
| Revenue | 336.11M |
| Revenue/Share | 0.6 |
| Gross Profit | 180.16M |
| EBITDA | 28.3M |
| Net Income | -35.22M |
| Diluted EPS | -0.08 |
Balance Sheet
| Total Cash | 12.23M |
| Total Cash/Share | 0.02 |
| Total Debt | 370.62M |
| Total Debt/Equity | 2.97 |
| Current Ratio | 0.46 |
| Book Value Per Share | 0.23 |
Price History
| 52-Week Change | -42.28 |
| 52-Week High | 0.41 |
| 52-Week Low | 0.21 |
| Moving Average 50 Days | 0.25 |
| Moving Average 200 Days | 0.29 |
Statistics
| Average Volume | 49,289 |
| Shares Outstanding | 535.05M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 18:17 |
| Last Split Date | January 29, 2020 |
AD
